Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.

Gerhardsson L, Lundh T, Minthon L, Londos E.

Dement Geriatr Cogn Disord. 2008;25(6):508-15. doi: 10.1159/000129365. Epub 2008 May 5.

PMID:
18463412
2.

Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.

Gerhardsson L, Blennow K, Lundh T, Londos E, Minthon L.

Dement Geriatr Cogn Disord. 2009;28(1):88-94. doi: 10.1159/000233353. Epub 2009 Aug 12.

PMID:
19672066
3.

Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.

Basun H, Forssell LG, Wetterberg L, Winblad B.

J Neural Transm Park Dis Dement Sect. 1991;3(4):231-58. Review.

PMID:
1772577
4.

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

Boström F, Hansson O, Gerhardsson L, Lundh T, Minthon L, Stomrud E, Zetterberg H, Londos E.

Neurobiol Aging. 2009 Aug;30(8):1265-71. doi: 10.1016/j.neurobiolaging.2007.10.018. Epub 2008 Jan 8.

PMID:
18191875
5.

Patterns of levels of biological metals in CSF differ among neurodegenerative diseases.

Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T.

J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.

PMID:
21292280
6.
7.

Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

Diamandis EP, Scorilas A, Kishi T, Blennow K, Luo LY, Soosaipillai A, Rademaker AW, Sjogren M.

Clin Biochem. 2004 Mar;37(3):230-7.

PMID:
14972646
8.

Decreased plasma and cerebrospinal fluid levels of stem cell factor in patients with early Alzheimer's disease.

Laske C, Stellos K, Stransky E, Seizer P, Akcay O, Eschweiler GW, Leyhe T, Gawaz M.

J Alzheimers Dis. 2008 Nov;15(3):451-60.

PMID:
18997298
9.

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, Wittorf A, Soekadar S, Richartz E, Koehler N, Bartels M, Buchkremer G, Schott K.

J Psychiatr Res. 2007 Aug;41(5):387-94. Epub 2006 Mar 22.

PMID:
16554070
10.

Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease.

Shetty HU, Holloway HW, Schapiro MB.

Clin Chem. 1996 Feb;42(2):298-302.

11.

Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease.

Abe T, Tohgi H, Isobe C, Murata T, Sato C.

J Neurosci Res. 2002 Nov 1;70(3):447-50.

PMID:
12391605
12.
13.

[Plasma, red cell, and cerebrospinal fluid folate in Alzheimer's disease].

Abalan F, Zittoun J, Boutami C, Dugrais G, Manciet G, Decamps A, Antoniol B.

Encephale. 1996 Nov-Dec;22(6):430-4. French.

PMID:
10901835
14.

Correlation between metal ions and clinical findings in subjects affected by Alzheimer's disease.

Bomboi G, Marchione F, Sepe-Monti M, De Carolis A, Bianchi V, Medda E, Pino A, Bocca B, Forte G, D'Ippolito C, Giubilei F.

Ann Ist Super Sanita. 2005;41(2):205-12.

15.

Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.

Szabo ST, Harry GJ, Hayden KM, Szabo DT, Birnbaum L.

Toxicol Sci. 2016 Apr;150(2):292-300. doi: 10.1093/toxsci/kfv325. Epub 2015 Dec 31.

16.

Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease.

Rubio JC, de Bustos F, Molina JA, Jiménez-Jiménez FJ, Benito-León J, Martín MA, Campos Y, Ortí-Pareja M, Cabrera-Valdivia F, Arenas J.

J Neurol Sci. 1998 Mar 5;155(2):192-5.

PMID:
9562266
17.

Metals and metallothionein in the liver of raccoons: utility for environmental assessment and monitoring.

Burger J, Lord CG, Yurkow EJ, McGrath L, Gaines KF, Brisbin IL Jr, Gochfeld M.

J Toxicol Environ Health A. 2000 Jun;60(4):243-61.

PMID:
10914690
18.

Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease.

Gerhardsson L, Lundh T, Londos E, Minthon L.

J Neural Transm (Vienna). 2011 Jun;118(6):957-62. doi: 10.1007/s00702-011-0605-x. Epub 2011 Mar 4.

PMID:
21373763
19.

Blood levels of toxic and essential metals in motor neuron disease.

Pamphlett R, McQuilty R, Zarkos K.

Neurotoxicology. 2001 Jun;22(3):401-10.

PMID:
11456341
20.

Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease.

Molina JA, Jiménez-Jiménez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, González-Muñoz MJ, de Bustos F, Porta J, Ortí-Pareja M, Zurdo M, Barrios E, Martínez-Para MC.

J Neural Transm (Vienna). 1998;105(4-5):479-88.

PMID:
9720975

Supplemental Content

Support Center